Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Up 150.0% in June

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPYGet Free Report) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 500 shares, a growth of 150.0% from the May 31st total of 200 shares. Based on an average daily volume of 900 shares, the days-to-cover ratio is currently 0.6 days.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPY stock opened at $50.70 on Friday. Hikma Pharmaceuticals has a 12-month low of $42.23 and a 12-month high of $56.63. The firm’s 50 day moving average is $49.57 and its 200 day moving average is $48.66.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

Read More

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.